These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 6085168)

  • 1. [Progress in the field of drug development. 17].
    Délenk-Heydenreich K; Henkler G; Keller U; Klotzbach M; Koch H; Müller W; Richter J
    Pharmazie; 1984 Nov; 39(11):725-37. PubMed ID: 6085168
    [No Abstract]   [Full Text] [Related]  

  • 2. [Progress in the field of drug developments. 13].
    Henkler G; Klotzbach M; Koch H; Müller W; Richter J
    Pharmazie; 1980; 35(9):517-39. PubMed ID: 6107937
    [No Abstract]   [Full Text] [Related]  

  • 3. [Progress in the area of drug development. Part 9].
    Hörig C; Klotzbach M; Koch H; Mayr E; Richter J
    Pharmazie; 1976 Aug; 31(8):499-527. PubMed ID: 11509
    [No Abstract]   [Full Text] [Related]  

  • 4. [Progress in the field of drug development. 7].
    Hörig C; Koch H; Mayr E; Richter J; Selchau M
    Pharmazie; 1974; 29(10-11):626-52. PubMed ID: 4155083
    [No Abstract]   [Full Text] [Related]  

  • 5. [Progress in the field of drug development. 11].
    Henkler G; Klotzbach M; Koch H; Müller W; Richter J
    Pharmazie; 1978 Sep; 33(9):551-67. PubMed ID: 32556
    [No Abstract]   [Full Text] [Related]  

  • 6. [Progress in the field of drug development. 4].
    Hörig C; Koch H; Mayr E; Selchau M
    Pharmazie; 1972 Jun; 27(6):347-90. PubMed ID: 4404246
    [No Abstract]   [Full Text] [Related]  

  • 7. [Progress in the area of drug development. 15].
    Henkler G; Klotzbach M; Koch H; Müller W; Richter J
    Pharmazie; 1982 Nov; 37(11):753-65. PubMed ID: 6131442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological implications of microsomal enzyme induction.
    Conney AH
    Pharmacol Rev; 1967 Sep; 19(3):317-66. PubMed ID: 4383307
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug activity as a function of the experimental pathological state].
    Quevauviller A
    Actual Pharmacol (Paris); 1967; 20():133-67. PubMed ID: 4388945
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug metabolism and drug interaction of anxiolytics].
    Uchimura N; Etou Y
    Ryoikibetsu Shokogun Shirizu; 2003; (38):612-6. PubMed ID: 12877062
    [No Abstract]   [Full Text] [Related]  

  • 11. Vitamins and drug metabolism with particular reference to vitamin C.
    Wilson CW
    Proc Nutr Soc; 1974 Dec; 33(3):231-8. PubMed ID: 4156589
    [No Abstract]   [Full Text] [Related]  

  • 12. New drugs and product approvals from 2001.
    Taylor SE
    Tex Dent J; 2002 Dec; 119(12):1186-98. PubMed ID: 12592740
    [No Abstract]   [Full Text] [Related]  

  • 13. [Progress in the area of drug development].
    Henkler G; Klotzbach M; Koch H; Mayr E; Richter J
    Pharmazie; 1977; 32(8-9):425-44. PubMed ID: 22872
    [No Abstract]   [Full Text] [Related]  

  • 14. Medicinal applications of indole derivatives.
    Sugden JK; Yoloye TO
    Pharm Acta Helv; 1978; 53(3-4):65-92. PubMed ID: 30094
    [No Abstract]   [Full Text] [Related]  

  • 15. [Potentiation of hexobarbital action as a method for experimental research on substances with depressive central activity].
    Carminati GM; Chiabotto L; Duzzi L
    Boll Chim Farm; 1972 May; 111(5):293-308. PubMed ID: 4403241
    [No Abstract]   [Full Text] [Related]  

  • 16. Tabular compilation of drug interactions.
    Hussar DA
    Am J Pharm Sci Support Public Health; 1969; 141(4):109-56. PubMed ID: 4390554
    [No Abstract]   [Full Text] [Related]  

  • 17. [UV-Spectrophotometry and its use in pharmacy].
    Krácmar J; Krácmarová J
    Pharmazie; 1971 Jan; 26(1):1-14. PubMed ID: 4101111
    [No Abstract]   [Full Text] [Related]  

  • 18. [Interactions and incompatibilities of drugs acting upon the central nervous system].
    Estler CJ
    Fortschr Med; 1973 Apr; 91(12):513-6. PubMed ID: 4702398
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiarrhythmic compounds.
    Szekeres L; Papp JG
    Prog Drug Res; 1968; 12():292-369. PubMed ID: 4389462
    [No Abstract]   [Full Text] [Related]  

  • 20. [Determination of drug concentrations in body fluid; possibilities and limitations. II. Determination of plasma levels as a part of individual patient treatment].
    Ariëns EJ; Simonis AM
    Ned Tijdschr Geneeskd; 1980 Jul; 124(29):1201-12. PubMed ID: 6106163
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.